Dyne Therapeutics (DYN) EBITDA (2019 - 2026)
Dyne Therapeutics (DYN) recorded EBITDA of -$181.06 million in Q2 2026, compared with -$115.29 million a year earlier.
Powered by 
Analysis
Dyne Therapeutics (DYN) EBITDA (2019 - 2026) Analysis & Trends
On a TTM basis, Dyne Therapeutics' EBITDA came in at -$534.74 million as of Jun 30, 2026; for FY2025, it came in at -$466.14 million.
- Across earlier years, EBITDA came in at -$342.19 million in FY2024, -$240.46 million in FY2023, -$169.28 million in FY2022 and -$148.93 million in FY2021.
- The Q2 2026 figure is the lowest quarterly EBITDA in data going back to Q3 2019.
- Per Business Quant, the preceding three quarters came in at -$124.68 million (Q1 2026), -$115.61 million (Q4 2025) and -$113.39 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,134.61 Bn | 1,103.20 Bn | 19.71 Bn | 12.29 Bn |
| 2 | Johnson & Johnson | 616.25 Bn | 534.77 Bn | 17.26 Bn | 9.10 Bn |
| 3 | AbbVie | 501.45 Bn | 474.56 Bn | 12.70 Bn | 8.33 Bn |
| 4 | Merck | 367.41 Bn | 321.79 Bn | 12.21 Bn | 999.00 Mn |
| 5 | Novartis Ag | 297.99 Bn | 261.98 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 261.44 Bn | 235.12 Bn | 12.86 Bn | 5.09 Bn |
| 7 | Amgen | 235.87 Bn | 191.27 Bn | 7.24 Bn | 4.63 Bn |
| 8 | Gilead Sciences | 190.66 Bn | 164.86 Bn | 6.22 Bn | -9.70 Bn |
| 9 | Pfizer | 169.40 Bn | 116.05 Bn | 10.94 Bn | 5.89 Bn |
| 10 | Dyne Therapeutics | 2.68 Bn | -1.09 Bn | - | -181.06 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -181.06 Mn |
| Mar 31, 2026 | -124.68 Mn |
| Dec 31, 2025 | -115.61 Mn |
| Sep 30, 2025 | -113.39 Mn |
| Jun 30, 2025 | -115.29 Mn |
| Mar 31, 2025 | -121.87 Mn |
| Dec 31, 2024 | -96.63 Mn |
| Sep 30, 2024 | -105.17 Mn |
| Jun 30, 2024 | -71.56 Mn |
| Mar 31, 2024 | -68.76 Mn |
| Dec 31, 2023 | -67.29 Mn |
| Sep 30, 2023 | -61.87 Mn |
| Jun 30, 2023 | -66.34 Mn |
| Mar 31, 2023 | -45.05 Mn |
| Dec 31, 2022 | -39.76 Mn |
| Sep 30, 2022 | -41.88 Mn |
| Jun 30, 2022 | -52.26 Mn |
| Mar 31, 2022 | -35.36 Mn |
| Dec 31, 2021 | -51.61 Mn |
| Sep 30, 2021 | -42.47 Mn |
API Access
Dyne Therapeutics EBITDA API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda&ticker=DYN&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda", "ticker": "DYN", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda&ticker=DYN&period=max&api_key=YOUR_API_KEY");
const data = await res.json();